Vir Advances Antibodies Against COVID-19, CEO Scangos Leads BIO’s Coronavirus Outreach

 
• By Mandy Jackson

Scrip talked to George Scangos about his dual roles in the pandemic response, helming Vir as the company tests antibody and siRNA approaches while working with BIO to facilitate coronavirus collaborations.

3DCoronavirus
Vir generated antibodies against coronaviruses before the COVID-19 pandemic • Source: Shutterstock

More from COVID-19

More from Scrip